MK-677
Also known as Ibutamoren
The short answer. Most people who report on MK-677 say it did not help (only 39% of 479 positive). It is most often used for appetite: 66% of 228 reports say that improved. There is a moderate body of research — 0 meta-analyses and 15 trials. The most common complaint is water retention.
From 978 mentions in total — the rest didn't say how it went and aren't counted.
What MK-677 does, according to users
Of the people who reported each effect, the share who said it got better.
3 more with fewer than 3 reports
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
At least one meta-analysis, or 5+ randomized controlled trials. The grade measures how much human research exists — read the conclusions below for what it found. 0 meta-analyses on PubMed ↗ · 15 randomized trials ↗
8 human trials on ClinicalTrials.gov test MK-677 — 5 completed, 1 recruiting now. See all on ClinicalTrials.gov ↗
- The Impact of Ibutamoren on Nonalcoholic Fatty Liver Disease · NAFLD, Nonalcoholic Fatty Liver · 2024
- Growth Hormone Secretagogue MK-0677 Effect on IGF-1 Levels in ESRD Patients · Chronic Kidney Disease, End Stage Renal Disease · 2010
- Study of MK0677 for the Treatment of Alzheimer's Disease (0677-030)(COMPLETED) · Alzheimer's Disease · 2006
Reports to the FDA
Adverse-event reports about supplements containing it, submitted to the US FDA by consumers and doctors.
6 reports name a product containing MK-677 (2015–2025); 3 involved hospitalization or worse. Most often reported:
- Mood altered · 1
- Decreased activity · 1
- Abdominal discomfort · 1
- Weight decreased · 1
- Headache · 1
- Diarrhoea · 1
A report doesn't prove the supplement caused the problem — many products contain several ingredients, and these counts can't tell you how often it happens. Source: FDA CAERS ↗ · raw reports (openFDA) ↗.
What government agencies say
Official records from US, Canadian and EU regulators, each linked to its source.
The FDA found MK-677 as an undeclared ingredient in 2 products sold as supplements, most recently on 2025-09-23. FDA tainted-products database ↗
NIH has funded 2 research projects with MK-677 in the title, $1,500,835 in total (1999–2009). NIH RePORTER ↗
Dosage people report
As stated by users — not a recommendation. Follow the label or your doctor.
Reported side effects
How often each side effect came up across all reports.
What users say
First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.
“From my own experience (also have suffered from poor sleep), i experienced a noticeable increase in sleep quality even with a low dose.”
“MK-677 lately... The sleep that it gives me is extremely fragmented and the total sleep time is reduced. But during the day I feel like I've had a better than average nights sleep.”
“It worked! My nausea and sickness was quickly replaced with an extreme hunger.”
“I've tried mk677 and it supposed to pharmacologically improve rem sleep and allowed me to get away with less sleep.”
MK-677 compared
Other options for appetite
Sources
- User reports: 978 mentions in public discussions, quoted with a link to each discussion (e.g. this thread ↗).
- PubMed (US National Library of Medicine, NIH): meta-analyses ↗ · randomized trials ↗
- ClinicalTrials.gov (NIH): registered trials ↗
- FDA tainted-products database ↗
- NIH RePORTER ↗
- US Food and Drug Administration: CAERS adverse-event reports ↗
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate